|
市場調查報告書
中國的動物用醫藥品製造產業：2010年
China veterinary pharmaceutical manufacturing industry, 2010
|
中國的動物用醫藥品製造產業：2010年 是由出版商ReportsFromChina.com在2010年03月所出版的。
這份英文市場調查報告書包含239 Pages 價格從美金2000起跳。
本報告，針對中國的動物用醫藥品製造產業進行分析，並彙整中國的經濟動向與動物用醫藥品製造產業的概要、參與市場的主要企業與其策略、投資動向、風險等，由下列摘要形式闡述。
第1章 動物用醫藥品製造產業的定義與其發展
第2章 動物用醫藥品製造產業的宏觀環境分析與其影響
- 現在的宏觀經濟發展與動向
- 最新的產業政策與相關法規/制度
- 上游/下游產業的發展狀況
第3章 動物用醫藥品製造產業的國際市場分析
第4章 動物用醫藥品製造產業的國內市場分析
第5章 動物用醫藥品製造產業的規模分析：2003年∼2009年
第6章 動物用醫藥品製造產業的資產分析：2003年∼2009年
第7章 動物用醫藥品製造產業的總產值：2003年∼2009年
- 總產值
- 總產值的分布：區域別
- 主要20家公司的比較
第8章 動物用醫藥品製造產業的業績收益分析：2003年∼2009年
- 總業績收益
- 總業績收益的分布：區域別
- 主要20家公司的比較
第9章 動物用醫藥品製造產業的總收益分析：2003年∼2009年
- 總收益
- 總收益的分布：區域別
- 主要20家公司的比較
第10章 動物用醫藥品製造產業的進出口分析：2009年
- 每月進出口狀況
- 進出口的分布：海關/國家別
- 進出口的分布：來源國家別
第11章 動物用醫藥品製造產業的競爭情況分析
第12章 動物用醫藥品製造產業的主要企業的能力比較分析
第13章 參與動物用醫藥品製造產業的企業經濟指標比較分析
第14章 動物用醫藥品製造產業開發上的課題與克服策略
第15章 動物用醫藥品製造產業的企業發展策略分析與建議
第16章 動物用醫藥品製造產業的投資行動與投資報酬率比較分析
第17章 動物用醫藥品製造產業的投資環境與投資風險分析
第18章 動物用醫藥品製造產業的現狀與最新技術的應用動向
第19章 動物用醫藥品製造產業的發展預測
Abstract
China veterinary pharmaceutical manufacturing Industry, 2010 is valuable for
anyone who wants to invest in the veterinary pharmaceutical manufacturing
industry, to get Chinese investments; to import into China or export from
China, to build factories and take advantage of lower costs in China, to
partner with one of the key Chinese corporations, to get market shares as
China is boosting its domestic needs; to forecast the future of the world
economy as China is leading the way; or to compete in the segment. The report
provides in-depth analysis and detailed insight into the veterinary
pharmaceutical manufacturing industry, market drivers, key enterprises and
their strategies, as well as technologies and investment status, risks and
trends.
Data sources: Governmental statistics organizations, market research
(monitoring) centers, industry associations and institutions, import and
export statistics organizations, and others.
This report is divided into 9 parts 19 chapters as follow:
Part 1 - Industry Overview
- 1. Industry definition and development overview
- 2. Industry macroscopic environment and its influence analysis
- 3. Industry international market analysis
- 4. Industry domestic market analysis
Part 2 - Basic indices
- 5. Analysis of the industry' s scale and condition: 2005-2009
- 6. Status analysis of gross assets analysis: 2005-2009
Part 3 - Economic operation
- 7. Analysis of gross industrial output: 2005-2009
- 8. Industry sales income analysis: 2005-2009
- 9. Industry gross profit analysis
- 10. Industry import/export analysis in 2009
Part 4 - Competition landscape
- 11. Industry competition landscape analysis
- 12. Industry key enterprises' competitive power comparison (top 20)
Part 5 - Key enterprises
- 13. Comparative analysis of the economic indicators of the
industry' s key enterprises
Part 6 - Business strategy
- 14. Development bottlenecks and coping strategies in Industry
- 15. Enterprise development strategy analysis and recommendations in
Industry
Part 7 - Market investment
- 16. Comparison and analysis of investment activity coefficient and
rate of return on investment in Industry
- 17. Industry investment environment and risks analysis
Part 8 - Technology
- 18. Status and trends of the newest technology applications in
Industry
Part 9 - Developments and trends
- 19. Development trends and operation capacity forecast for 2010-2014
There more than 200 figures and tables.
Report format: PDF
Knowledge is power. If you want to invest in, import into/from, partner with,
or compete against any of the companies in this field, then China veterinary
pharmaceutical manufacturing Industry, 2010 is required reading.
Table of Contents
Part 1 - Industry Overview
1. Definition of veterinary pharmaceutical manufacturing industry and its development
- 1.1 Definition of the industry and its core products
- 1.1.1 Definition of the industry
- 1.1.2 Core products
- 1.2 Main characteristics of the industry and a history of its development
- 1.2.1 Characteristics of the industry
- 1.2.2 Course of industrial development
2. Analysis on the macro environment of veterinary pharmaceutical manufacturing industry and its impact
- 2.1 Current macroeconomic developments and trends
- 2.1.1 China macroeconomic development in 2005-2009
- 2.1.2 China' s macroeconomic development trend in 2010
- 2.2 Latest industry policies and related laws and regulations
- 2.3 Upstream, downstream industry development status
- 2.3.1 Upstream industry development status of veterinary medicine
- 2.3.2 Downstream industry development status of veterinary medicine
3. Analysis on international market in veterinary pharmaceutical manufacturing industry
- 3.1 Current development of its international market
- 3.2 Levels of development in key countries and regions
- 3.3 Analysis of movements and trends in the international market ...
4. Analysis on domestic market in veterinary pharmaceutical manufacturing industry
- 4.1 Current development of its domestic market
- 4.2 Trends in the domestic market
- 4.3 Sub-industry development status
Part 2 - Basic indices
5. Analysis on scale of China' s veterinary pharmaceutical manufacturing industry: 2003- 2009
- 5.1 Analysis on number of enterprises: 2003-2009
- 5.1.1 Overall situation
- 5.1.2 Gross industrial output value by size
- 5.1.3 Gross industrial output value by ownership
- 5.2 Analysis on number of loss-making enterprises: 2003-2009
- 5.2.1 Overall situation
- 5.2.2 Gross industrial output value by size
- 5.2.3 Gross industrial output value by ownership
- 5.3 Total loss: 2003-2009
- 5.3.1 Overall situation
- 5.3.2 Gross industrial output value by size
- 5.3.3 Gross industrial output value by ownership
- 5.4 Analysis on number of employees: 2003-2009
- 5.4.1 Overall situation
- 5.4.2 Gross industrial output value by size
- 5.4.3 Gross industrial output value by ownership
6. Analysis on assets in veterinary pharmaceutical manufacturing industry: 2003- 2009
- 6.1 Status and analysis of gross assets: 2003-2009
- 6.1.1 Overall situation
- 6.1.2 Gross industrial output value by size
- 6.1.3 Gross industrial output value by ownership
- 6.2 Status of fixed assets: 2003-2009
- 6.2.1 Overall situation
- 6.2.2 Gross industrial output value by size
- 6.2.3 Gross industrial output value by ownership
- 6.3 Gross current asset analysis: 2003-2009
- 6.3.1 Overall situation
- 6.3.2 Gross industrial output value by size
- 6.3.3 Gross industrial output value by ownership
Part 3 - Economic operation
7. Analysis on gross industrial output value in veterinary pharmaceutical manufacturing industry' s: 2003-2009
- 7.1 Gross industrial output value: 2003-2009
- 7.1.1 Overall situation
- 7.1.2 Gross industrial output value by size
- 7.1.3 Gross industrial output value by ownership
- 7.2 Distribution of gross industrial output value by geographic area: 2009
- 7.3 Comparison of the top 20 enterprises (based on highest gross output
value): 2009
8. Analysis on sales revenue of veterinary pharmaceutical manufacturing industry: 2003- 2009
- 8.1 Total industry sales revenue: 2003-2009
- 8.1.1 Overall situation
- 8.1.2 Gross industrial output value by size
- 8.1.3 Gross industrial output value by ownership
- 8.2 Distribution of sales revenue by geographic area: 2009
- 8.3 Comparison of the top 20 enterprises (based on highest gross sales
revenue): 2009
9. Analysis on gross profit of veterinary pharmaceutical manufacturing industry: 2003- 2009
- 9.1 Gross profit analysis:2003-2009
- 9.1.1 Overall situation
- 9.1.2 Gross industrial output value by size
- 9.1.3 Gross industrial output value by ownership
- 9.2 Distribution of gross profit by geographic area: 2009
- 9.3 Comparison of the top 20 enterprises (based on highest gross profit):
2009
10. Analysis on import & export in veterinary pharmaceutical manufacturing industry in 2009
- 10.1 Monthly status of import/export: 2009
- 10.1.1 Import monthly status in 2009
- 10.1.2 Export monthly status in 2009
- 10.2 Distribution of import/export customs and countries in 2009
- 10.2.1 Distribution of import customs in 2009
- 10.2.2 Distribution of export customs in 2009
- 10.3 Distribution of import/export source countries in 2009
- 10.3.1 Distribution of import source countries in the industry: 2009
- 10.3.2 Distribution of export source countries in 2009
Part 4 - Competitive landscape
11. Analysis on competitive landscape of veterinary pharmaceutical manufacturing industry
- 11.1 Competitive landscape of regional markets
- 11.1.1 Distribution by region
- 11.1.2 Distribution by province, city, and autonomous region
- 11.2 Comparison of the enterprises' market share
12. Comparative analysis on key enterprises' competency in veterinary pharmaceutical manufacturing industry
- 12.1 Comparative analysis of the key enterprises' total assets
- 12.2 Comparative analysis of the key enterprises' employees
- 12.3 Comparative analysis of the key enterprises' annual revenues
- 12.4 Comparison analysis of key enterprises' export turnover value
- 12.5 Comparison analysis of key enterprises' total profit
- 12.6 Comparison of key enterprises' overall competitive power
Part 5 - Key enterprises
13. Comparative analysis on the economic indicators of key enterprises in veterinary pharmaceutical manufacturing industry
- 13.1 Zhejiang Guobang Pharmaceutical Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.2 Shandong Xinfa Pharmaceutical Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.3 Chongqing Three Gorges Animal Husbandry Group Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.4 Harbin Weike Biotechnology Development Co.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.5 Shandong Qifa Pharmaceutical Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.6 JinYu Baoling Bio-pharmaceutical Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.7 Guangdong Tengjun Veterinary Medicine Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.8 Ningxia Duowei Tairui Pharmaceutical Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.9 Qingdao Yibang Bio-engineering Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.10 QianYuanHao Biological Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.11 Shenyang Hefeng Bio-technology Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.12 Yangzhou Tianhe Pharmaceutical & Chemical Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.13 Pucheng County ChiaTai Biochemistry Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.14 Guangdong DaHuaNong Animal Health Products Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.15 Zhumadia Huazhong ChiaTai Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.16 Jinggangshan Veterinary Pharmaceutical Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.17 Jiangxi Bomei Pharmaceutical Factory
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.18 Yueyang Shenli Bio-technology Co., Ltd..
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.19 Foshan Municipal Nanhai Dongfang Aolong Pharmaceutical Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
- 13.20 Qilu Animal Health Products Co., Ltd.
- A. Enterprises' basic information
- B. Enterprises' business operation analysis
- C. Analysis of enterprise' s liabilities
- D. Enterprise' operating expense and cost analysis
- E. Enterprise' additional expenses analysis
- F. Enterprise industrial intermediate inputs and cash flow
Part 6 - Business strategy
14. Development bottlenecks in veterinary pharmaceutical manufacturing industry and coping strategies
- 14.1 Development bottlenecks
- 14.2 Coping strategies
15. Analysis on enterprise development strategies for veterinary pharmaceutical manufacturing industry and recommendations
- 15.1 Analysis of enterprise business strategies and recommendations
- 15.2 Analysis of enterprise marketing strategies and recommendations
Part 7 - Market investment
16. Comparison and analysis of investment activity coefficients and investment returns of veterinary pharmaceutical manufacturing industry
- 16.1 Comparative analysis of the industry activity coefficients
- 16.1.1 Related industry activity coefficient comparison in 2009
- 16.1.2 Analysis of the industry activity coefficients: 2003-2009
- 16.1.3 From the perspective of Zhongjing Zongheng' s (CMRN)
- 16.2 Comparison and analysis of the industry' s investment returns
- 16.2.1 Comparison of investment returns in related industries: 2009
- 16.2.2 Analysis on investment returns of the industry: 2003-2009
- 16.1.3 From the perspective of Zhongjing Zongheng' s (CMRN)
17. Analysis on investment environment and investment risks in veterinary pharmaceutical manufacturing industry
- 17.1 Analysis of the industry' s investment environment
- 17.1.1 Economic environment
- 17.1.2 Policy environment
- 17.1.3 Technical environment
- 17.2 Analysis of the industry' s investment risks
- 17.2.1 Policy risk
- 17.2.2 Market risk
- 17.2.3 Technological risk
- 17.2.4 Financial risk
- 17.2.5 Operation & Management risk
- 17.3 Investment recommendations (Zhongjing Zongheng' s CMRN)
Part 8 - Technology
18. Current situation and trends of the newest technology application in veterinary pharmaceutical manufacturing industry
- 18.1 Current situation of the newest technology applications
- 18.2 Trends in technological development in the industry
19. Forecast of development trends and operating capacity for veterinary pharmaceutical manufacturing industry
- 19.1 Industry development tendency
- 19.2 Forecast of industry' s operating capability in 2010-2014
- 19.2.1 Total assets forecast in 2010-2014
- 19.2.2 Gross industrial output value forecast: 2010-2014
- 19.2.3 Sales revenue forecast: 2010-2014
- 19.2.4 Total revenue forecast in 2010-2014
|
